State Street’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,270
| Closed | -$40.4K | – | 4274 |
|
|
2025
Q1 | $40.4K | Hold |
4,270
| – | – | ﹤0.01% | 4125 |
|
|
2024
Q4 | $38.3K | Buy |
4,270
+376
| +10% | +$3.37K | ﹤0.01% | 4149 |
|
|
2024
Q3 | $250K | Hold |
3,894
| – | – | ﹤0.01% | 3775 |
|
|
2024
Q2 | $292K | Buy |
3,894
+380
| +11% | +$28.5K | ﹤0.01% | 3708 |
|
|
2024
Q1 | $420K | Buy |
3,514
+2,990
| +571% | +$357K | ﹤0.01% | 3696 |
|
|
2023
Q4 | $43.5K | Hold |
524
| – | – | ﹤0.01% | 4218 |
|
|
2023
Q3 | $41.5K | Hold |
524
| – | – | ﹤0.01% | 4330 |
|
|
2023
Q2 | $30.6K | Hold |
524
| – | – | ﹤0.01% | 4531 |
|
|
2023
Q1 | $22.6K | Hold |
524
| – | – | ﹤0.01% | 4670 |
|
|
2022
Q4 | $26.9K | Hold |
524
| – | – | ﹤0.01% | 4683 |
|
|
2022
Q3 | $53K | Hold |
524
| – | – | ﹤0.01% | 4645 |
|
|
2022
Q2 | $63K | Buy |
524
+23
| +5% | +$2.77K | ﹤0.01% | 4672 |
|
|
2022
Q1 | $103K | Hold |
501
| – | – | ﹤0.01% | 4631 |
|
|
2021
Q4 | $100K | Hold |
501
| – | – | ﹤0.01% | 4580 |
|
|
2021
Q3 | $139K | Buy |
501
+8
| +2% | +$2.22K | ﹤0.01% | 4469 |
|
|
2021
Q2 | $176K | Buy |
+493
| New | +$176K | ﹤0.01% | 4242 |
|
|
2018
Q3 | – | Sell |
-18
| Closed | -$34K | – | 3776 |
|
|
2018
Q2 | $34K | Hold |
18
| – | – | ﹤0.01% | 3701 |
|
|
2018
Q1 | $62K | Hold |
18
| – | – | ﹤0.01% | 3651 |
|
|
2017
Q4 | $75K | Hold |
18
| – | – | ﹤0.01% | 3620 |
|
|
2017
Q3 | $91K | Hold |
18
| – | – | ﹤0.01% | 3638 |
|
|
2017
Q2 | $89K | Sell |
18
-4
| -18% | -$19.8K | ﹤0.01% | 3561 |
|
|
2017
Q1 | $147K | Buy |
+22
| New | +$147K | ﹤0.01% | 3523 |
|